Review of metabolic, immunologic, and virologic consequences of suboptimal vitamin D levels in HIV infection

AIDS Patient Care and STDs

Volumn 26, Issue 9, 2012, Pages 516-525

  Griffin, Allen T ^a   Arnold, Forest W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DARUNAVIR; EFAVIRENZ; NEVIRAPINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; BODY MASS; BONE DENSITY; CANDIDIASIS; CAUCASIAN; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; SEX RATIO; SIDE EFFECT; SKIN COLOR; SUBSTANCE ABUSE; SUNLIGHT; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV SEROPOSITIVITY; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; UNITED STATES; VIRAL LOAD; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84865483829     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0145     Document Type: Review

References (54)

1. Wallace H. Tuberculous glands and sinuses treated with calciferol. Lancet 1946;2:88.
2. Powell G, Pearsall P, Wigley J. Calciferol in the treatment of cutaneous tuberculosis. Br Med J 1948;1:386-389.
3. Zhang C, Zhao L, Ma L, et al. Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis. Dig Dis Sci 2012 57: 182-188.
4. Leow L, Simpson T, Cursons R, Karalus N, Hancox R. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 2011;16:611-616.
5. Tang A, Graham N, Kirby A, McCall L, Willett W, Saah A. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993;138:937-951. (Pubitemid 24002360)
6. Leone S, Gregis G, Quinzan G, et al. Causes of death and risk factors among HIV-infected persons in the HAART era: Analysis of a large urban cohort. Infection 2011;39:13-20.
7. Beard J, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol 2011;50:194-200.
8. Ginde A, Liu M, Camargo C. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632.
9. Forrest K, Stuhldreher W. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011;31:48-54.
10. Kim J, Gandhi V, Psevdos G, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses 2012;28:235- 241.
11. Rodri'guez M, Daniels B, Gunawardene S, Robbins G. High frequency of vitamin D deficiency in ambulatory HIVpositive patients. AIDS Res Hum Retroviruses 2009;25: 9-14.
12. Adeyemi O, Agniel D, French A, et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011;57:197-204.
13. Wasserman P, Rubin D. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDs 2010;24:223-227.
14. Crutchley R, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey K. Risk factors for vitamin D deficiency in HIVinfected patients in the south central United States. AIDS Res Hum Retroviruses 2012;28:454-459.
15. Dao C, Patel P, Overton P et al. Low Vitamin D among HIVinfected adults: Prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011;52:396-405.
16. Okano T, Yasumura M, Mizuno K, Kobayashi T. In vivo and in vitro conversion of 7-dehydrocholesterol into vitamin D3 in rat skin by ultraviolet ray's irradiation. J Nutr Sci Vitaminol (Tokyo) 1978;24:47-56. (Pubitemid 8304958)
17. Mueller N, Fux C, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010;24:1127-1134.
18. Stephensen C, Marquis G, Kruzich L, Douglas S, Aldrovandi G, Wilson C. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr 2006;83:1135-1141. (Pubitemid 44713115)
19. Conrado T, Miranda-Filho Dde B, Ximenes R, et al. Vitamin D deficiency in HIV-infected women on antiretroviral therapy living in the tropics. J Int Assoc Physicians AIDS Care (Chic) 2011;10:239-245.
20. Haripasad N, Nallani S, Sane R, Buckley D, Buckley A, Desai P. Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital. J Clin Pharmacol 2004;44:1273-1281. (Pubitemid 39391486)
21. Brown T, McComsey G. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010;15:425-429.
22. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. AIDS Res Hum Retroviruses 2011;27:29-34.
23. Conesa-Botella A, Florence E, Lynen L, Colebunders R, Menten J, Moreno-Reyes R. Decrease of vitamin D concentration in patients with HIV infection on a nonnucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther 2010;7:40.
24. Welz T, Childs K, Ibrahim F, et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010;24:1923-1928.
25. Fux C, Baumann, Furrer H, Mueller N. Is lower serum 25-hydroxy vitamin D associated with efavirenz or the nonnucleoside reverse transcriptase inhibitor class? AIDS 2011;25:876-878.
26. Rockstroh J, Stoehr A, Duiculescu D, et al. Analysis of vitamin D and parathyroid hormone in the SENSE trial: Etravirine versus efavirenz in treatment-naïve HIV-1 infected patients. Antivir Ther 2010;15:A42.
27. Rosenvinge M, Gedela K, Copas A, et al. Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010;54:496-499.
28. Masiá M, Padilla S, Robledano C, Lo'pez N, Ramos J, Gutie ́rrez F. Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res Hum Retroviruses 2012; 28:242-246.
29. Vescini F, Cozzi-Lepri A, Borderi M, et al. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 2011;58:163-172.
30. Milazzo L, Mazzali C, Bestetti G, et al. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res 2011;9:186-193.
31. Aloia J, Cohn S, Vaswani A, Yeh J, Yuen K, Ellis K. Risk factors for postmenopausal osteoporosis. Am J Med 1985;78:95-100. (Pubitemid 15159625)
32. Tomazic J, Ul K, Volcansek G, et al. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population. Wien Klin Wochenschr 2007;119:639-646. (Pubitemid 350239502)
33. Yin M, Lu D, Cremers S, et al. Short-term bone loss in HIVinfected premenopausal women. J Acquir Immune Defic Syndr 2010;53:202-208.
34. Moradmand Badie B, Soori T, Kheirandish P, et al. Evaluation of bone mineral density in Iranian HIV/AIDS patients. Acta Med Iran 2011;49:460-467.
35. Szep Z, Guaraldi G, Shah S, et al. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS 2011;25:525-529.
36. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS 2006;20:2165-2174. (Pubitemid 44684707)
37. Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: The Swiss HIV Cohort Study. Clin Infect Dis 2011;53:1130-1139.
38. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009;205:255-260.
39. Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho J. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010;24:243-253.
40. Shikuma C, Seto T, Liang C, et al. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses (in press
41. Choi A, Lo J, Mulligan K, et al. Association of vitamin D insufficiency with carotid intima-media thickness in HIVinfected persons. Clin Infect Dis 2011;52:941-944.
42. Ross A, Judd S, Kumari M, et al. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther 2011;16:555-563.
43. Lai H, Gerstenblith G, Fishman EK, et al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis 2012;54:1747-1755.
44. de la Torre M, Torres C, Nieto G, et al. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J Infect Dis 2008;197:405-410. (Pubitemid 351263422)
45. Barber Y, Rubio C, Ferna'ndez E, Rubio M, Fibla J. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIVseropositive injection drug users. J Infect Dis 2001;184: 1279-1288. (Pubitemid 33055572)
46. Campbell G, Spector S. Hormonally active vitamin D3 (1alpha 25 dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011;286:18890-18902.
47. Fawzi W, Msamanga G, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23-32. (Pubitemid 38857244)
48. de Luis D, Bachiller P, Aller R, et al. Relation among micronutrient intakes with CD4 count in HIV infected patients. Nutr Hosp 2002;17:285-289. (Pubitemid 44616131)
49. Mehta S, Mugusi FM, Spiegelman D. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDs 2011;25:579-585.
50. Mehta S, Giovannucc E, Mugusi F, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010;19; 5:e8770.
51. Viard J, Souberbielle J, Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA study. AIDS 2011;25:1305-1315.
52. Institute of Medicine for the National Academies. November 2010. www.iom.edu/Reports/2010/Dietary-Reference- Intakes-for-Calcium-and-Vitamin-D. aspx (Last accessed June 20, 2012
53. Mehta S, Spiegelman D, Aboud S, et al. Lipid-soluble vitamins A, D, and E in HIV-infected pregnant women in Tanzania. Eur J Clin Nutr 2010;64:808-817.
54. Deeb K, Trump D, Johnson C. Vitamin D signalling pathways in cancer: Potential for anticancer therapeutics. Nat Rev Cancer 2007;7:684-700. (Pubitemid 47327412)